157 related articles for article (PubMed ID: 11470780)
1. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase.
Vanderwerf SM; Cooper MJ; Stetsenko IV; Lutsenko S
J Biol Chem; 2001 Sep; 276(39):36289-94. PubMed ID: 11470780
[TBL] [Abstract][Full Text] [Related]
2. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity.
Walker JM; Tsivkovskii R; Lutsenko S
J Biol Chem; 2002 Aug; 277(31):27953-9. PubMed ID: 12029094
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal metal-binding site 2 of the Wilson's Disease Protein plays a key role in the transfer of copper from Atox1.
Walker JM; Huster D; Ralle M; Morgan CT; Blackburn NJ; Lutsenko S
J Biol Chem; 2004 Apr; 279(15):15376-84. PubMed ID: 14754885
[TBL] [Abstract][Full Text] [Related]
4. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
Tsivkovskii R; Efremov RG; Lutsenko S
J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
[TBL] [Abstract][Full Text] [Related]
5. The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein.
Huster D; Lutsenko S
J Biol Chem; 2003 Aug; 278(34):32212-8. PubMed ID: 12794172
[TBL] [Abstract][Full Text] [Related]
6. The Lys1010-Lys1325 fragment of the Wilson's disease protein binds nucleotides and interacts with the N-terminal domain of this protein in a copper-dependent manner.
Tsivkovskii R; MacArthur BC; Lutsenko S
J Biol Chem; 2001 Jan; 276(3):2234-42. PubMed ID: 11053407
[TBL] [Abstract][Full Text] [Related]
7. Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.
Lutsenko S; Efremov RG; Tsivkovskii R; Walker JM
J Bioenerg Biomembr; 2002 Oct; 34(5):351-62. PubMed ID: 12539962
[TBL] [Abstract][Full Text] [Related]
8. The Wilson's disease protein expressed in Sf9 cells is phosphorylated.
Vanderwerf SM; Lutsenko S
Biochem Soc Trans; 2002 Aug; 30(4):739-41. PubMed ID: 12196182
[TBL] [Abstract][Full Text] [Related]
9. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.
Lutsenko S; Tsivkovskii R; Walker JM
Ann N Y Acad Sci; 2003 Apr; 986():204-11. PubMed ID: 12763797
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of the copper-transporting ATPase ATP7B (the Wilson's disease protein) expressed in insect cells.
Tsivkovskii R; Eisses JF; Kaplan JH; Lutsenko S
J Biol Chem; 2002 Jan; 277(2):976-83. PubMed ID: 11677246
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling of the nucleotide-binding domain of Wilson's disease protein: location of the ATP-binding site, domain dynamics and potential effects of the major disease mutations.
Efremov RG; Kosinsky YA; Nolde DE; Tsivkovskii R; Arseniev AS; Lutsenko S
Biochem J; 2004 Aug; 382(Pt 1):293-305. PubMed ID: 15147237
[TBL] [Abstract][Full Text] [Related]
12. The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.
Morgan CT; Tsivkovskii R; Kosinsky YA; Efremov RG; Lutsenko S
J Biol Chem; 2004 Aug; 279(35):36363-71. PubMed ID: 15205462
[TBL] [Abstract][Full Text] [Related]
13. Copper transport and its defect in Wilson disease: characterization of the copper-binding domain of Wilson disease ATPase.
Sarkar B
J Inorg Biochem; 2000 Apr; 79(1-4):187-91. PubMed ID: 10830865
[TBL] [Abstract][Full Text] [Related]
14. N-terminal domains of human copper-transporting adenosine triphosphatases (the Wilson's and Menkes disease proteins) bind copper selectively in vivo and in vitro with stoichiometry of one copper per metal-binding repeat.
Lutsenko S; Petrukhin K; Cooper MJ; Gilliam CT; Kaplan JH
J Biol Chem; 1997 Jul; 272(30):18939-44. PubMed ID: 9228074
[TBL] [Abstract][Full Text] [Related]
15. Localization of the Wilson's disease protein product to mitochondria.
Lutsenko S; Cooper MJ
Proc Natl Acad Sci U S A; 1998 May; 95(11):6004-9. PubMed ID: 9600907
[TBL] [Abstract][Full Text] [Related]
16. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches.
Lutsenko S; Petris MJ
J Membr Biol; 2003 Jan; 191(1):1-12. PubMed ID: 12532272
[TBL] [Abstract][Full Text] [Related]
17. The regulation of catalytic activity of the menkes copper-translocating P-type ATPase. Role of high affinity copper-binding sites.
Voskoboinik I; Mar J; Strausak D; Camakaris J
J Biol Chem; 2001 Jul; 276(30):28620-7. PubMed ID: 11373292
[TBL] [Abstract][Full Text] [Related]
18. A single PDZ domain protein interacts with the Menkes copper ATPase, ATP7A. A new protein implicated in copper homeostasis.
Stephenson SE; Dubach D; Lim CM; Mercer JF; La Fontaine S
J Biol Chem; 2005 Sep; 280(39):33270-9. PubMed ID: 16051599
[TBL] [Abstract][Full Text] [Related]
19. Copper-induced conformational changes in the N-terminal domain of the Wilson disease copper-transporting ATPase.
DiDonato M; Hsu HF; Narindrasorasak S; Que L; Sarkar B
Biochemistry; 2000 Feb; 39(7):1890-6. PubMed ID: 10677240
[TBL] [Abstract][Full Text] [Related]
20. The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation.
Bartee MY; Ralle M; Lutsenko S
Biochemistry; 2009 Jun; 48(24):5573-81. PubMed ID: 19405516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
